Lieke Joosten

1.9k total citations
53 papers, 1.5k citations indexed

About

Lieke Joosten is a scholar working on Surgery, Epidemiology and Oncology. According to data from OpenAlex, Lieke Joosten has authored 53 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 23 papers in Epidemiology and 21 papers in Oncology. Recurrent topics in Lieke Joosten's work include Neuroendocrine Tumor Research Advances (22 papers), Pancreatic function and diabetes (22 papers) and Diabetes and associated disorders (14 papers). Lieke Joosten is often cited by papers focused on Neuroendocrine Tumor Research Advances (22 papers), Pancreatic function and diabetes (22 papers) and Diabetes and associated disorders (14 papers). Lieke Joosten collaborates with scholars based in Netherlands, Switzerland and United States. Lieke Joosten's co-authors include Otto C. Boerman, Martin Gotthardt, Maarten Brom, Wim J.G. Oyen, Peter Laverman, Annemarie Eek, Wim B. van den Berg, George Kollias, Fons A. J. van de Loo and Martin Béhé and has published in prestigious journals such as Diabetes, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Lieke Joosten

52 papers receiving 1.5k citations

Peers

Countries citing papers authored by Lieke Joosten

Since Specialization

Citations

This map shows the geographic impact of Lieke Joosten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieke Joosten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieke Joosten more than expected).

Fields of papers citing papers by Lieke Joosten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lieke Joosten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieke Joosten. The network helps show where Lieke Joosten may publish in the future.

Co-authorship network of co-authors of Lieke Joosten

This figure shows the co-authorship network connecting the top 25 collaborators of Lieke Joosten. A scholar is included among the top collaborators of Lieke Joosten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lieke Joosten. Lieke Joosten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas 2024 ·EJNMMI Research ·(unknown), (unknown), Mijke Buitinga, Sanne A. M. van Lith, Lieke Joosten, Cathelijne Frielink, E. Smeets, Martijn W.J. Stommel, Marion van der Kolk, Bastiaan E. de Galan, Maarten Brom, Marti Boss, Martin Gotthardt	0
2	New Radiolabeled Exendin Analogues Show Reduced Renal Retention 2023 ·Molecular Pharmaceutics ·Lieke Joosten, Cathelijne Frielink, (unknown), (unknown), Fritz Andreae, Mark Konijnenberg, Sandra Heskamp, Martin Gotthardt, Maarten Brom	4
3	Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists 2023 ·Pharmaceuticals ·Berthold A. Nock, (unknown), Lieke Joosten, Rosalba Mansi, Θεοδοσία Μάινα	25
4	Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39) 2022 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Sanne A. M. van Lith, Annemarie Kip, Cathelijne Frielink, Lieke Joosten, Roland Brock, Martin Gotthardt	5
5	Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68Ga]Ga-DOTA-E-[c(RGDfK)]2 PET/CT 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Mark Rijpkema, Samantha Y.A. Terry, Janneke D.M. Molkenboer‐Kuenen, Lieke Joosten, (unknown), Adriana C. H. van Engen–van Grunsven, Johannes H.A.M. Kaanders, Sjoert Pegge, Otto C. Boerman, Willem L. J. Weijs, Matthias A.W. Merkx, Carla M.L. van Herpen, Robert P. Takes, Erik H.J.G. Aarntzen, Wim J.G. Oyen	14
6	Monitoring ¹¹¹In-labelled polyisocyanopeptide (PIC) hydrogel wound dressings in full-thickness wounds 2019 ·Biomaterials Science ·(unknown), Lieke Joosten, (unknown), Otto C. Boerman, Paul H. J. Kouwer, Esther Middelkoop, Alan E. Rowan, John A. Jansen, X. Frank Walboomers, Frank A. D. T. G. Wagener	30
7	PET/MRI enables simultaneous in vivo quantification of β-cell mass and function 2019 ·Theranostics ·(unknown), Gregory D. Bowden, (unknown), Lieke Joosten, (unknown), Volker Nischwitz, Gisela Drews, Andreas Maurer, Martin Gotthardt, Andreas M. Schmid, Bernd J. Pichler	18
8	Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa 2018 ·Molecules ·Stéphane Demine, Alexander Balhuizen, Vinciane Debaille, Lieke Joosten, (unknown), (unknown), Isabelle Millard, Raphaël Scharfmann, Dominique Egrise, Serge Goldman, Piero Marchetti, Martin Gotthardt, Sophie Laurent, Carmen Burtéa, Décio L. Eizirik	9
9	Characterization of 111In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors 2018 ·Scientific Reports ·(unknown), Lieke Joosten, Otto C. Boerman, Maarten Brom, Martin Gotthardt	7
10	Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3 2017 ·Scientific Reports ·(unknown), (unknown), Karolina M. Andralojc, Mijke Buitinga, (unknown), Cathelijne Frielink, Desirée L. Bos, Lieke Joosten, Otto C. Boerman, Maarten Brom, Martin Gotthardt	18
11	Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan 2017 ·Scientific Reports ·Lieke Joosten, Maarten Brom, Martin Schäfer, Otto C. Boerman, Eberhard Weihe, Martin Gotthardt	1
12	SPECT-OPT multimodal imaging enables accurate evaluation of radiotracers for β-cell mass assessments 2016 ·Scientific Reports ·(unknown), (unknown), Lieke Joosten, Cathelijne Frielink, Maria Eriksson, Maarten Brom, Ulf Ahlgren, Martin Gotthardt	11
13	The effect of purification of Ga-68-labeled exendin on in vivo distribution 2016 ·EJNMMI Research ·Maarten Brom, Gerben M. Franssen, Lieke Joosten, Martin Gotthardt, Otto C. Boerman	19
14	Combined Optical Coherence and Fluorescence Microscopy to assess dynamics and specificity of pancreatic beta-cell tracers 2015 ·Scientific Reports ·(unknown), (unknown), Arno Bouwens, Daniel Szlag, Antonio López‐Quílez, Lieke Joosten, (unknown), Maarten Brom, Martin Gotthardt, Anne Grapin‐Botton, Theo Lasser	17
15	Non-invasive quantification of the beta cell mass by SPECT with 111In-labelled exendin 2014 ·Diabetologia ·Maarten Brom, (unknown), Lieke Joosten, Cathelijne Frielink, Thomas Bouckenooghe, Paul F.J.W. Rijken, Karolina M. Andralojc, Burkhard Göke, Marion de Jong, Décio L. Eizirik, Martin Béhé, Tony Lahoutte, Wim J.G. Oyen, Cees J. Tack, Marcel Janssen, Otto C. Boerman, Martin Gotthardt	109
16	A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma 2013 ·Carcinogenesis ·Theo S. Plantinga, Irene Costantini, Bas Heinhuis, (unknown), (unknown), Benno Küsters, Mihai G. Netea, A. R. M. M. Hermus, Johannes W. A. Smit, C A Dinarello, Lieke Joosten, Romana T. Netea‐Maier	32
17	Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis 2012 ·Diabetologia ·Karolina M. Andralojc, Mangala Srinivas, Maarten Brom, Lieke Joosten, I. Jolanda M. de Vries, Décio L. Eizirik, Otto C. Boerman, P. Mêda, Martin Gotthardt	51
18	68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET 2010 ·European Journal of Nuclear Medicine and Molecular Imaging ·Maarten Brom, Wim J.G. Oyen, Lieke Joosten, Martin Gotthardt, Otto C. Boerman	109
19	Amplifying elements of arthritis and joint destruction 2007 ·Annals of the Rheumatic Diseases ·Wim B. van den Berg, (unknown), Lieke Joosten, Shahla Abdollahi‐Roodsaz, Marije I. Koenders	45
20	Role of tumour necrosis factor α in experimental arthritis: separate activity of interleukin 1β in chronicity and cartilage destruction 1999 ·Annals of the Rheumatic Diseases ·Wim B. van den Berg, Lieke Joosten, George Kollias, Fons A. J. van de Loo	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact